You just read:

Gilead Receives Approval in Canada for Expanded Indication of EPCLUSA® (Sofosbuvir/Velpatasvir) for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

News provided by

Gilead Sciences, Inc.

Sep 21, 2017, 05:59 ET